May 23, 2016
1 min read
Save

Five important news items from CCR

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio Rheumatology features the top five stories from the Congress of Clinical Rheumatology Annual Meeting. More of Healio Rheumatology’s live coverage, including video interviews with researchers, can be found by clicking here.


Study explores link between rheumatoid arthritis, cardiovascular disease

DESTIN, Fla. — A speaker here at the Congress of Clinical Rheumatology Annual Meeting presented data that address the effect of rheumatoid arthritis therapies on cardiovascular and metabolic disease. Read more.

 

New drugs, better communication are critical in treatment of osteoporosis

DESTIN, Fla. — New drugs and more effective physician-to-patient communication are critical in the treatment of osteoporosis, according to a speaker at the Congress of Clinical Rheumatology Annual Meeting.  Read more.

 

Speaker presents key guidelines for the management of rheumatoid arthritis

DESTIN, Fla. — There are three overarching principals and 10 recommendations rheumatologists should consider when managing the care of patients with rheumatoid arthritis, according to a speaker at the Congress of Clinical Rheumatology Annual Meeting, here. Read more.

 

New management tactics emerge for patients with difficult-to-treat gout

DESTIN, Fla. — Emerging methods of care could improve the management of difficult-to-treat gout, according to a speaker at the Congress of Clinical Rheumatology Annual Meeting, here. Read more.

 

Speaker provides updates on the management of Behçet’s syndrome

DESTIN, Fla. — A speaker here at the Congress of Clinical Rheumatology Annual Meeting provided an update on Behçet’s syndrome, including a review of its clinical manifestations and new therapy options. Read more.